Last reviewed · How we verify
NCT07060534: BEST-U
Building Healthy Eating and Self-Esteem Together for University Students
NA trial testing Building Healthy Eating and Self-Esteem Together for University Students in Eating Disorders (Excluding Anorexia Nervosa) in 74 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | University of Kansas |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 74 |
| Start date | 23 June 2026 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Building Healthy Eating and Self-Esteem Together for University Students
- Present-Centered Therapy
Conditions studied
- Eating Disorders (Excluding Anorexia Nervosa) — all drugs for Eating Disorders (Excluding Anorexia Nervosa) →
- Binge-Eating Disorder — all drugs for Binge-Eating Disorder →
Sponsor
University of Kansas
Who can join
Adults 18 to 65, any sex, with Eating Disorders (Excluding Anorexia Nervosa) or Binge-Eating Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Eating disorders (EDs) are a critical concern on college campuses. Moreover, since the COVID-19 pandemic, ED prevalence has increased by 62% in university women and 140% in university men. Resources are inadequate to meet demand, leading to delays in students' access to treatment. Untreated (or poorly treated) EDs result in greater healthcare utilization and costs to students, as well as lower academic achievement and increased psychiatric disability and mortality, suggesting a critical need for quality ED treatment on university campuses and to rethink treatment delivery. One way to address this gap in care delivery is to improve treatment accessibility and scalability, such as dissemination via mobile apps. Guided self-help Cognitive Behavior Therapy (CBT-gsh) is a cost-effective option that can be delivered by non-traditional service providers, such as nurses and physicians. Our scientific premise is that the mHealth CBT-gsh app, Building Healthy Eating and Self-Esteem Together for University Students (BEST-U), will lead to reductions in binge eating (primary outcome) through reductions in dietary restraint and weight/shape concerns (target mechanisms). Prior to implementing BEST-U at other universities, we need to test the intervention in a real-world setting with the end goal of disseminating at scale. Our objectives are to: 1) conduct an effectiveness test of BEST-U compared to a similar dose of present-centered therapy (PCT) in students with non-low weight binge-spectrum EDs and 2) test target mechanisms that lead to changes in binge eating. To accomplish our objectives, we will test the following specific aims: 1) conduct an RCT of BEST-U (N=37) compared to a similar dose of PCT (N=37) in students with non-low weight binge-spectrum EDs; 2) test target mechanisms that lead to changes in binge eating and other ED symptoms; and 3) characterize barriers and facilitators to implementation across two campuses. Our exploratory aim will test food reinforcement and food-choice impulsivity as potential target mechanisms or response moderators of rapid response in binge eating. Given that few studies have identified underlying mechanisms that explain how CBT-gsh works and for whom, this study may lead to improved ability to tailor or modify existing CBT-gsh or lead to novel intervention development for students who are unlikely to respond rapidly (or at all) to first line CBT interventions for EDs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07060534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eating Disorders (Excluding Anorexia Nervosa)
Currently open trials in the same condition.
- NCT07037017 — CBT Effects on Neural, Physiological, and Attentional Responses in Anorexia Nervosa · NA · recruiting
Other University of Kansas trials
Trials by the same sponsor.
- NCT07301060 — Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control · NA · recruiting
- NCT07283510 — Community-based Functional Fitness for Adults Aging With Mobility Disability · NA · completed
- NCT05190926 — Smart Technology for Anorexia Nervosa Recovery · NA · unknown
- NCT05880966 — Functional Fitness for Overweight or Obese Adults with Mobility Disabilities · NA · active not recruiting
- NCT05799599 — Peer Interventions for Preschoolers With Autism · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07060534 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Kansas
- Last refreshed: 14 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07060534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing